The new edition of CPhI (Convention on Pharmaceutical Ingredients) scheduled in Milan from 8 to 10 October promises to be of great importance for the Faravelli Group. The event represents a valuable opportunity to present the portfolio of active ingredients and excipients and to consolidate meaningful connections with professionals and companies in the pharmaceutical sector.
Faravelli, with a successful presence in the industry for several decades, has distinguished itself not only by the quality of its raw materials, but also by offering comprehensive services and customized, continuous solutions. Internationally important partnerships, such as the one with Meggle, with whom it celebrated its 50th anniversary in 2023, and new partners such as Nisso Soda, starting in April 2024, testify to its constant commitment to excellence and innovation. Constant dialogue with customers has revealed a growing demand to expand the product offering, including a richer proposition of active ingredients (APIs).
The API sector is undergoing rapid growth and change, with an increasing focus on quality, regulatory compliance, technological innovation and personalization of treatments.
According to market projections, the industry will reach $306.90 billion by 2029, growing at 7.22% over the forecast period (2024-2029). This scenario reflects significant opportunities for the Faravelli Group.
The acquisition of Deltapharma S.L. in 2021, specialising in the distribution of APIs and authorized for import from non-EU countries, has further consolidated the global presence, enabling important synergies and an expansion of activities, particularly in Spain.
The company also intensified its scouting for new suppliers and invested in specialized personnel, creating a competitive and extensive sales network through its foreign offices.
Although the pharmaceutical sector remains traditionalist, the project is attracting considerable interest.
The Faravelli Group is determined to offer innovative, high-quality solutions and invites industry professionals to visit CPhI Milan, stand 6D52.
CONTACT INFORMATION
Email: pharma@faravelli.it
